Market Tracker

02/12 5:16pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

88.39
Delayed Data
As of Feb 12
 +4.95 / +5.93%
Today’s Change
69.33
Today|||52-Week Range
263.81
-13.04%
Year-to-Date

Today’s Trading

Previous close83.44
Today’s open85.72
Day’s range85.15 - 89.07
Volume5,312,404
Average volume (3 months)12,912,393
Market cap$30.2B
Dividend yield--
Data as of 4:01pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+23.07%
Earnings growth (next 5 years)+15.49%
Revenue growth (last year)+43.22%
P/E ratio36.6
Price/Sales5.93
Price/Book5.56

Competitors

 Today’s
change
Today’s
% change
SHPGShire+8.90+5.89%
ALXNAlexion Pharmaceutic...+5.75+4.25%
MYLMylan NV+0.41+0.98%
VRTXVertex Pharmaceutica...+3.52+4.42%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateFebruary 25, 2016
EPS forecast (this quarter)$2.60
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Howard Bradley Schiller
Chief Financial Officer &
Executive Vice President
Robert L. Rosiello
Corporate headquarters
Laval, Quă©bec

Forecasts